Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protein tyrosine phosphatase, receptor type, C | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Methoxy mycolic acid synthase 2 MmaA2 (methyl mycolic acid synthase 2) (MMA2) (hydroxy mycolic acid synthase) | protein tyrosine phosphatase, receptor type, C | 87 aa | 85 aa | 25.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | adenosylhomocysteinase | 0.0907 | 0.6018 | 0.6018 |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.1466 | 1 | 0.5 |
Trypanosoma brucei | S-adenosylhomocysteine hydrolase, putative | 0.1466 | 1 | 0.5 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0173 | 0.0785 | 0.5 |
Plasmodium falciparum | adenosylhomocysteinase | 0.1466 | 1 | 1 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0907 | 0.6018 | 0.6018 |
Schistosoma mansoni | adenosylhomocysteinase | 0.1466 | 1 | 1 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.1466 | 1 | 1 |
Toxoplasma gondii | S-Adenosyl homocysteine hydrolase | 0.1466 | 1 | 1 |
Echinococcus granulosus | adenosylhomocysteinase | 0.1466 | 1 | 1 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0173 | 0.0785 | 0.0785 |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.1466 | 1 | 0.5 |
Schistosoma mansoni | adenosine deaminase-related | 0.0173 | 0.0785 | 0.0785 |
Echinococcus multilocularis | adenosine deaminase | 0.0173 | 0.0785 | 0.0785 |
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.0785 | 0.0418 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0907 | 0.6018 | 0.6018 |
Echinococcus granulosus | adenosine deaminase | 0.0173 | 0.0785 | 0.0785 |
Echinococcus multilocularis | adenosylhomocysteinase | 0.1466 | 1 | 1 |
Schistosoma mansoni | adenosine deaminase | 0.0173 | 0.0785 | 0.0785 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.1466 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosylhomocysteinase SahH (S-adenosyl-L-homocysteine hydrolase) (adohcyase) | 0.1466 | 1 | 1 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0173 | 0.0785 | 0.0785 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.046 | 0.2832 | 0.2221 |
Mycobacterium ulcerans | adenosine deaminase | 0.0173 | 0.0785 | 0.0785 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0907 | 0.6018 | 0.6018 |
Plasmodium vivax | adenosylhomocysteinase(S-adenosyl-L-homocystein e hydrolase), putative | 0.1466 | 1 | 1 |
Treponema pallidum | adenosine deaminase | 0.0173 | 0.0785 | 0.5 |
Mycobacterium leprae | putative S-adenosyl-L-homocysteine hydrolase SahH | 0.1466 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0173 | 0.0785 | 0.0785 |
Leishmania major | S-adenosylhomocysteine hydrolase | 0.1466 | 1 | 1 |
Loa Loa (eye worm) | adenosylhomocysteinase | 0.1466 | 1 | 1 |
Mycobacterium ulcerans | S-adenosyl-L-homocysteine hydrolase | 0.1466 | 1 | 1 |
Toxoplasma gondii | adenosylhomocysteinase, putative | 0.1466 | 1 | 1 |
Entamoeba histolytica | adenosylhomocysteinase, putative | 0.1466 | 1 | 1 |
Leishmania major | adenine aminohydrolase | 0.0173 | 0.0785 | 0.0785 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 10 uM | Cytotoxicity of the compound measured against human T-cells | ChEMBL. | 11356112 |
IC50 (binding) | = 0.5 uM | In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrate | ChEMBL. | 11356112 |
IC50 (binding) | = 0.5 uM | In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrate | ChEMBL. | 11356112 |
IC50 (functional) | = 1.3 uM | In vitro inhibition of human T-cell proliferation | ChEMBL. | 11356112 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.